Dragonfly Energy files exhibit 3.1 to its definitive proxy statement
Dragonfly Energy filed an exhibit detailing its matters for the upcoming annual meeting, including proposals for ratification of accountants and election of directors.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Dragonfly Energy filed an exhibit detailing its matters for the upcoming annual meeting, including proposals for ratification of accountants and election of directors.
Ernst & Young LLP filed a consent allowing its independent report to be included in various ongoing SEC registration statements, filed October 8, 2026.
Tetra Technologies Inc. agreed to amend its credit agreement with Silver Point Finance as the administrative agent, effective October 2, 2026.
Perspective Therapeutics announced FDA Fast Track Designation for PSV359 treating rare fibroblast activation protein-positive solitary fibrous tumors.
Vylor Inc. has filed an amended indenture to govern the issuance of debt securities, with U.S. Bank Trust Company serving as trustee.
Toppoint Holdings Inc. confirmed it is unaware of any undisclosed developments causing recent stock volatility, despite unusual trading activity.
Ally Financial Inc. has filed a Third Amended and Restated Bylaws document. These amendments detail regulations regarding the transfer of stock, issuance of uncertificated stock, a…
Angel Oak Mortgage REIT filed an 8-K amending its bylaws effective October 6, 2026. The modification is primarily a governance update.
Pulse Biosciences enrolled 164 patients in its pivotal NANOPULSE-AF study ahead of schedule, demonstrating strong investigator interest in its cardiac catheter system.
Pine Tree Acquisition Corp. updated its Memorandum of Association to increment its share capital. Market relevance: The increase in authorized Class A ordinary shares enhances the …
Lipocine及其合作伙伴Verity Pharma宣布，Health Canada已批准TLANDO用于加拿大男性睾丸激素缺乏症治疗，Verity Pharma计划于2026年底前启动商业化。
Transglobal Management Group filed an amended and restated Articles of Incorporation increasing authorized Common Stock to 40 billion shares and Preferred Stock to 20 million share…
Southern Cross Acquisition II Corp. announced that its common stock, warrants, and rights will begin separate trading on October 8, under the symbols SCAT, SCATW, and SCATR, respec…
Canadian Derivatives Clearing Corporation filed an 8-K dated September 30, 2026, listing underlying interests. This relates to the registration of its options for sale in the U.S.
Biolife Solutions amended its certificate of incorporation, reducing authorized shares from 100 million to 1 million. This is a corporate administrative update related to the creat…
Paramount Skydance Corporation amended and restated its certificate of incorporation, effective October 6, 2026, while notifying the SEC of the corresponding form 8-K. This is a no…
Bluejay Diagnostics released preliminary clinical data from the SYMON-II study supporting the Symphony IL-6 test's potential for mortality risk assessment in sepsis, marking a key …
The company received a notification from Nasdaq confirming it has complied with periodic filing requirements as of October 1, 2026, resolving a previous listing standard issue.
Furmonertinib failed to significantly improve progression-free survival, though favorable secondary efficacy metrics are noted.
B&G Foods terminated a deal to sell Green Giant Canada after failing to secure regulatory approval, stating the company will continue to own the asset and evaluate strategic altern…